Vaucluse, Australia

MacKay Fabienne

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Apoxis S.a., Biogen Idec Ma Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: MacKay Fabienne. Retrieved from https://idiyas.com/inventor/mackay-fabienne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of MacKay Fabienne

Introduction

MacKay Fabienne is a notable inventor based in Vaucluse, Australia. He has made significant contributions to the field of immunology, particularly through his work on the BAFF receptor. His innovative approach has led to advancements in understanding immunoregulatory agents.

Latest Patents

MacKay holds one patent for the BAFF receptor (BCMA), which is an immunoregulatory agent. This patent introduces a novel receptor in the TNF family known as BAFF-R. Additionally, it includes chimeric molecules and antibodies to BAFF-R, along with methods of use for these innovations.

Career Highlights

Throughout his career, MacKay has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Biogen Idec MA Inc. and Apoxis S.A. His work in these organizations has contributed to the development of groundbreaking therapies and treatments.

Collaborations

MacKay has collaborated with several esteemed professionals in his field, including Browning Jeffrey and Ambrose Christine. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

MacKay Fabienne's contributions to immunology through his patent on the BAFF receptor exemplify the impact of innovative thinking in science. His career reflects a commitment to advancing medical research and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…